Similar Articles
291 Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review
292 Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
293 Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives
294 Assessing recent recurrence after hepatectomy for hepatitis B-related hepatocellular carcinoma by a predictive model based on sarcopenia
295 Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma
296 Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
297 Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
298 Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
299 Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
300 MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA